Literature DB >> 9783277

Intensity modulated conformal therapy for intracranial lesions.

W Grant1, R B Cain.   

Abstract

The Peacock planning and delivery system was used to create treatment plans and deliver these plans to patients. The system involves an arc therapy delivery of small (2 cm long) slices of radiation combined with indexing of the couch to achieve target coverage. Two clinical examples are shown to demonstrate the system's capability and evaluate the resources required to produce and deliver the plans. One plan is an optic sheath meningioma and the other is a craniopharyngioma that surrounded the optic chiasm. The optic sheath meningioma was treated to 50 Gy in 25 fractions. The treatment involved delivery of two arcs. The total time to set up the patient and deliver the treatment was less than 15 min. Planning and plan validation after computed tomography required approximately 3 days. The patient had 100% restoration of her field of vision and is stable 3 years post therapy. The second patient is a 9-year-old who had a craniopharyngioma which surrounded the optic chiasm. The tumor was treated to 50.4 Gy in 28 fractions and the dose to the optic chiasm was limited to 45 Gy. The treatment required three arcs and total treatment time was less than 20 min. The patient is stable 15 months post therapy. The system is able to create and deliver radiation patterns that are unique. These plans can be created and delivered in times that rival conventional forward planning conformal radiotherapy systems that cannot produce or conveniently deliver such plans.

Entities:  

Mesh:

Year:  1998        PMID: 9783277     DOI: 10.1016/s0958-3947(98)00015-6

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  6 in total

Review 1.  Radiotherapy for brain tumors.

Authors:  M P Mehta; W A Tomé; G H Olivera
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

2.  Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative.

Authors:  S Pitz; G Becker; U Schiefer; H Wilhelm; B Jeremic; M Bamberg; E Zrenner
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

3.  Primary and Secondary Optic Nerve Sheath Meningioma.

Authors:  Elena Solli; Roger E Turbin
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

4.  Efficacy of intensity-modulated radiation therapy for optic nerve sheath meningioma.

Authors:  Hiroyuki Sasano; Keigo Shikishima; Manabu Aoki; Tsutomu Sakai; Yuki Tsutsumi; Tadashi Nakano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-03       Impact factor: 3.117

Review 5.  Meningioma: current treatment options and future directions.

Authors:  Kevin P McMullen; Volker W Stieber
Journal:  Curr Treat Options Oncol       Date:  2004-12

Review 6.  Optic nerve sheath meningiomas: prevalence, impact, and management strategies.

Authors:  Richard T Parker; Christopher A Ovens; Clare L Fraser; Chameen Samarawickrama
Journal:  Eye Brain       Date:  2018-10-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.